Liver Cancer Diagnosis and Treatment Planning: Understanding and Improving Access to Liver Tumor Boards and Multidisciplinary Care
Nov
2026
Description
Many patients with liver cancer do not receive a referral to a multidisciplinary liver tumor board—especially not in a timely manner. This may result in misdiagnosis, unnecessary diagnostic testing that delays the diagnosis, and/or delayed or failure to initiate recommended treatments.
Presenters explore what multidisciplinary liver tumor boards are and how they streamline the diagnosis and treatment of patients with liver cancer. Key topics include what makes a great multidisciplinary liver tumor board, and why multidisciplinary care is so important in liver cancer. Speakers aim to increase awareness of and access to multidisciplinary liver tumor boards and multidisciplinary care for all persons living with liver cancer.
Presentations
2:00 PM
- 2:15 PM
Convention Center - Mile High Ballroom 4DEF
What Is a Multidisciplinary Liver Tumor Board?
Tamar H Taddei, MD, MD, FAASLD | Presenter
2:15 PM
- 2:30 PM
Convention Center - Mile High Ballroom 4DEF
Why Are Multidisciplinary Liver Tumor Boards Critical for the Management of Liver Cancer?
Marina Serper, MD, MS, FAASLD | Presenter
2:30 PM
- 2:45 PM
Convention Center - Mile High Ballroom 4DEF
Challenges in Timely Initiation of Treatment for Hepatocellular Carcinoma in the Community
Evelyn Rivera | Presenter
2:45 PM
- 3:00 PM
Convention Center - Mile High Ballroom 4DEF
Challenges in Early Disease and Diagnosis
Nicole Wright-Derks, Healthcare Technician/Prolia Coordinator | Presenter
3:00 PM
- 3:30 PM
Convention Center - Mile High Ballroom 4DEF
Panel Discussion
Andrea Wilson Woods, MPW | Moderator
